Evidence map›Paper›PMID 38297153›Full record

ArticleEye (London, England)2024

Diagnosis of multiple sclerosis using optical coherence tomography supported by explainable artificial intelligence.

F J Dongil-Moreno, M Ortiz, A Pueyo, L Boquete, E M Sánchez-Morla, D Jimeno-Huete, J M Miguel, R Barea, E Vilades, E Garcia-Martin

Abstract read
In one paragraph

Article in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  3. Article
  4. Article
  5. Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  6. Article
  7. From lesion detection to outcome prediction: artificial intelligence and deep learning applications in multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

F J Dongil-MorenoBiomedical Engineering Group, Department of Electronics, University of Alcalá, Alcalá de Henares, Spain.
M OrtizSchool of Physics, University of Melbourne, Melbourne, 3010, VIC, Australia.
A PueyoDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
L BoqueteBiomedical Engineering Group, Department of Electronics, University of Alcalá, Alcalá de Henares, Spain.
E M Sánchez-MorlaInstitute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, 28007, Madrid, Spain.
D Jimeno-HueteBiomedical Engineering Group, Department of Electronics, University of Alcalá, Alcalá de Henares, Spain.
J M MiguelBiomedical Engineering Group, Department of Electronics, University of Alcalá, Alcalá de Henares, Spain.
R BareaBiomedical Engineering Group, Department of Electronics, University of Alcalá, Alcalá de Henares, Spain.
E ViladesDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
E Garcia-MartinDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. egmvivax@yahoo.com.ORCID http://orcid.org/0000-0001-6258-2489

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesStudy of retinal structure based on optical coherence tomography (OCT) data can facilitate early diagnosis of relapsing-remitting multiple sclerosis (RRMS). Although artificial intelligence can provide highly reliable diagnoses, the results obtained must be explainable. SUBJECTS/

methodsThe study included 79 recently diagnosed RRMS patients and 69 age matched healthy control subjects. Thickness (Avg) and inter-eye difference (Diff) features are obtained in 4 retinal layers using the posterior pole protocol. Each layer is divided into six analysis zones. The Support Vector Machine plus Recursive Feature Elimination with Leave-One-Out Cross Validation (SVM-RFE-LOOCV) approach is used to find the subset of features that reduces dimensionality and optimises the performance of the classifier.

resultsSVM-RFE-LOOCV was used to identify OCT features with greatest capacity for early diagnosis, determining the area of the papillomacular bundle to be the most influential. A correlation was observed between loss of layer thickness and increase in functional disability. There was also greater functional deterioration in patients with greater asymmetry between left and right eyes. The classifier based on the top-ranked features obtained sensitivity = 0.86 and specificity = 0.90.

conclusionsThere was consistency between the features identified as relevant by the SVM-RFE-LOOCV approach and the retinotopic distribution of the retinal nerve fibres and the optic nerve head. This simple method contributes to implementation of an assisted diagnosis system and its accuracy exceeds that achieved with magnetic resonance imaging of the central nervous system, the current gold standard. This paper provides novel insights into RRMS affectation of the neuroretina.

Indexed as

Artificial IntelligenceMultiple Sclerosis, Relapsing-RemittingTomography, Optical CoherenceAdultCase-Control StudiesEarly DiagnosisFemaleHumansMaleMiddle AgedRetinaSupport Vector Machine

Identifiers

PMID38297153
PMCPMC11126721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.